STAT protein family and cardiovascular diseases: overview of pathological mechanisms and therapeutic implications
- 23 March 2024
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-10
Abstract
Globally, cardiovascular diseases (CVD) are one of the significant causes of death and are considered a major concern of human society. One of the most crucial objectives of scientists is to reveal the mechanisms associated with the pathogenesis of CVD, which has attracted the attention of many scientists. Accumulating evidence showed that the signal transducer and activator of transcription (STAT) signaling pathway is involved in various physiological and pathological processes. According to research on the molecular mechanisms of CVDs, the STAT family of proteins is one of the most crucial players in these diseases. Numerous studies have demonstrated the undeniable relevance of STAT family proteins in various CVDs. The aim of this review is to shed light on how STAT signaling pathways are related to CVD and the potential for using these signaling pathways as therapeutic targets.Keywords
This publication has 71 references indexed in Scilit:
- STAT4 regulates cardiomyocyte apoptosis in rat models of diabetic cardiomyopathyActa Histochemica, 2022
- Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial functionBasic Research in Cardiology, 2021
- Low shear stress damages endothelial function through STAT1 in endothelial cells (ECs)Journal of Physiology and Biochemistry, 2020
- Dysregulated expression of STAT1, miR‐150, and miR‐223 in peripheral blood mononuclear cells of coronary artery disease patients with significant or insignificant stenosisJournal of Cellular Biochemistry, 2019
- STAT1‐avtiviated LINC00961 regulates myocardial infarction by the PI3K/AKT/GSK3β signaling pathwayJournal of Cellular Biochemistry, 2019
- Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formationBasic Research in Cardiology, 2012
- Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate–Induced CardioprotectionCardiovascular Drugs and Therapy, 2012
- Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusionBasic Research in Cardiology, 2010
- Ethanolamine is a novel STAT-3 dependent cardioprotective agentBasic Research in Cardiology, 2010
- Role of STAT3 in Ischemic PreconditioningJournal of Molecular and Cellular Cardiology, 2001